Noctrix Health

Focus: Noctrix Health is a neurology-focused biotech company developing neuromodulation devices for restless legs syndrome, headquartered in Pleasanton, CA. The company is early-stage with a concentrated pipeline targeting a single indication through multiple device modalities.

Neurology

Profile data last refreshed 5h ago · AI intelligence enriched 2w ago

Open Jobs

14+2 this month

Stable — net +2 jobs in 30d

5 added, 3 removed. Backfill posture.

Should You Work at Noctrix Health?

AI assessment

High-risk, high-upside opportunity best suited for early-stage biotech veterans comfortable with uncertainty and commercial groundfloor roles; verify funding, regulatory status, and launch timeline before committing.

Why Work Here

Opportunity to shape commercialization strategy: 9 of 11 open roles are commercial positions, indicating a company ramping toward market launch with significant responsibility for early hires

Data completeness

2/9 — Limited

Company HealthSolid

Pipeline

Early-stage

8 total

LOE Risk

Protected

No near-term cliffs

Hiring

Stable

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Tonic Motor Activation

Restless Legs Syndrome

N/A

Clinical Trials (2)

NCT07397247Tonic Motor Activation (TOMAC) Therapy in Patients With Restless Legs Syndrome and Dopaminergic Augmentation

N/A

Help build intelligence for Noctrix Health

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Focused therapeutic area: deep specialization in neurology and restless legs syndrome enables vertical expertise development in an underserved patient population

Device-based innovation: exposure to neuromodulation hardware, regulatory pathways, and reimbursement strategies distinct from traditional pharma

Watch Out For

Pre-revenue company with unknown funding and financials: no disclosed funding, revenue, or cash position creates uncertainty about runway and salary sustainability
Heavily commercial-weighted hiring suggests product approval or launch readiness may not yet be confirmed: 82% of roles are commercial/customer care, not R&D or medical affairs, signaling earlier-stage development than hiring profile implies
Single-indication focus creates portfolio risk: all 8 pipeline programs target restless legs syndrome only, leaving zero pipeline diversification if primary indication faces regulatory or market setbacks

Generated by Claude from Noctrix Health's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

NCT07675109Optimizing Extended-Duration (XD-) TOMAC Therapy for Restless Legs Syndrome (RLS)

N/A

NTX100

Restless Legs Syndrome

N/A

Clinical Trials (1)

NCT06076499A Post-Market Study for Long-Term Effectiveness and Safety of the TOMAC System for RLS

N/A

Noninvasive Peripheral Nerve Stimulation

Restless Legs Syndrome

N/A

Clinical Trials (1)

NCT04698343Noninvasive Peripheral Nerve Stimulation for Restless Legs Syndrome During Opioid Medication Reduction

N/A

NTX100 Neuromodulation System - Active

Restless Legs Syndrome

N/A

Clinical Trials (1)

NCT04874155Noninvasive Peripheral Nerve Stimulation for Medication-Refractory Primary RLS (The RESTFUL Study)

N/A

Investigational Noninvasive Neuromodulation Device

Restless Legs Syndrome

N/A

Clinical Trials (1)

NCT06866132Response to an Investigational Device in Patients With Restless Legs Syndrome

N/A

Noctrix Health NPNS device v1.0 - Active

Restless Legs Syndrome

N/A

Clinical Trials (1)

NCT04700683Noninvasive Peripheral Nerve Stimulation for Restless Legs Syndrome

N/A

NTX100 Neuromodulation System - Active

Restless Legs Syndrome

N/A

Clinical Trials (1)

NCT05214963Noninvasive Peripheral Nerve Stimulation for Medication-Naive and Medication-Refractory RLS

N/A

NTX100 Neuromodulation System

Restless Legs Syndrome

N/A

Clinical Trials (1)

NCT05196828Extension Study Evaluating NTX100 Neuromodulation System for Medication-Refractory Primary RLS

N/A

Interview Prep Quick Facts

Portfolio: 9 clinical trials

Open Roles: 14 active jobs

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo

Hiring Trend

Stable

Open Roles

Added

-0

Filled/Removed

Based on last 4 crawl cycles

Noctrix Health

Should You Work at Noctrix Health?

Why Work Here

Pipeline & Clinical Trials

Watch Out For

Open Jobs (14)

Head of Marketing

Senior Full Stack Software Engineer

Senior Digital Content & Growth Marketing Manager

Hiring Trend